Barry Gershuny
Psychiatry · Northbrook, ILNPI 1235145954
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $76,165 of the $96,465 with a category attached, or 79.0%. AbbVie accounts for 71.9% of it on its own, with 16 other manufacturers making up the rest. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 313 payments — averaging $308.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$69K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$18K
- Ironshore Pharmaceuticals Inc.$5K
- Corium, LLC$820
- Tris Pharma Inc$786
- Neos Therapeutics, LP$557
- plus $2K from 11 others
What the payments were for
- Consulting fees$9,50010%
- Speaking & faculty fees$76,16579%
- Travel & lodging$3,7114%
- Food & beverage$6,8007%
- Education$2890%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 159 | $69,311 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 34 | $17,972 |
| Ironshore Pharmaceuticals Inc. | 15 | $5,322 |
| Corium, LLC | 11 | $820 |
| Tris Pharma Inc | 15 | $786 |
| Neos Therapeutics, LP | 15 | $557 |
| Teva Pharmaceuticals USA, Inc. | 15 | $528 |
| Supernus Pharmaceuticals, Inc. | 3 | $331 |
| Otsuka America Pharmaceutical, Inc. | 10 | $249 |
| Alkermes, Inc. | 4 | $172 |
| E.r. Squibb & Sons, L.L.C. | 2 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $106 |
| Axsome Therapeutics, Inc. | 1 | $37 |
| Shire North American Group Inc | 2 | $33 |
| Vertical Pharmaceuticals, LLC | 2 | $32 |
| Lundbeck LLC | 2 | $30 |
| Tempus AI, Inc | 2 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$67,460
- CAPLYTA$17,294
- Jornay PM 20mg capsules (Bottle of 100)$4,544
- Azstarys$666
- Dyanavel XR$487
- LYBALVI$480
- JORNAY PM$354
- Adzenys XR-ODT$344
- Quillivant$245
- Quillichew ER$245
- QELBREE$232
- COBENFY$136
- REXULTI$118
- Austedo XR$109
How this compares
$96,465 in reported general payments places this provider in the 95th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisdexamfetamine Dimesylate | 20 | $3,433 |
| Duloxetine Hcl | 69 | $1,830 |
| Methylphenidate Er (La)Methylphenidate Hcl | 11 | $1,607 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 39 | $1,351 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 29 | $1,135 |
| Alprazolam ErAlprazolam | 12 | $1,045 |
| Bupropion Hcl SrBupropion Hcl | 58 | $863 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $850 |
| Gabapentin | 59 | $827 |
| Trazodone Hcl | 43 | $793 |
| Bupropion XlBupropion Hcl | 46 | $754 |
| Carbamazepine | 12 | $734 |
| Lamotrigine | 57 | $691 |
| Mirtazapine | 34 | $690 |
| Lorazepam | 29 | $590 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Northbrook
- Michael FeldNorthbrook$1.1M
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Mark ShukhmanSkokie$250K
- Abid NazeerOak Brook$228K
- Nitin ThaparOrland Park$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.